Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famciclovir pediatric formulation in children with varicella zoster infection
2015-004442-25Phase 3
- Sponsor
- Novartis
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of famciclovir in chickenpox (2 arms), sponsored by Novartis. Primary endpoints: Single-dose pharmacokinetics of famciclovir, Safety and tolerability of famciclovir (single-dose and multiple-dose) and 1 more.
02
Drugs
famciclovir
03
Conditions
chickenpox
Beyond the preview
Go deeper on 2015-004442-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004442-25.